EXAGEN INC. Stock-Based Compensation
EXAGEN INC. (XGN) reported Stock-Based Compensation of $1.64 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-04
- EXAGEN INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $980.00K, a 121.22% increase year-over-year.
- EXAGEN INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $655.00K, a 57.07% increase year-over-year.
- EXAGEN INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $705.00K, a 62.82% increase year-over-year.
- EXAGEN INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $593.00K, a 173.27% increase year-over-year.
- EXAGEN INC. share-based payment arrangement, noncash expense for fiscal 2025 was $2.16M, a 22.40% increase from fiscal 2024.
- EXAGEN INC. share-based payment arrangement, noncash expense for fiscal 2024 was $1.76M, a 51.26% decline from fiscal 2023.
- EXAGEN INC. share-based payment arrangement, noncash expense for fiscal 2023 was $3.62M, a 23.11% decline from fiscal 2022.
- EXAGEN INC. share-based payment arrangement, noncash expense for fiscal 2022 was $4.70M, a 0.51% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $980.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $1.64M 10-Q · filed 2026-08-04 | $2.34M derived: sum of 3 quarters · filed 2026-08-04 | $2.93M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $655.00K 10-Q · filed 2026-05-11 | $1.36M derived: sum of 2 quarters · filed 2026-05-11 | $1.95M derived: sum of 3 quarters · filed 2026-05-11 | $2.40M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $705.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $1.30M derived: sum of 2 quarters · filed 2026-03-10 | $1.74M derived: sum of 3 quarters · filed 2026-08-04 | $2.16M 10-K · filed 2026-03-10 |
| 2025-09-30 | $593.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $1.04M derived: sum of 2 quarters · filed 2026-08-04 | $1.45M 10-Q · filed 2025-11-04 | $1.89M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $443.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $860.00K 10-Q · filed 2026-08-04 | $1.29M derived: sum of 3 quarters · filed 2026-08-04 | $1.51M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $417.00K 10-Q · filed 2026-05-11 | $850.00K derived: sum of 2 quarters · filed 2026-05-11 | $1.07M derived: sum of 3 quarters · filed 2026-05-11 | $1.63M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $433.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $650.00K derived: sum of 2 quarters · filed 2026-03-10 | $1.21M derived: sum of 3 quarters · filed 2026-03-10 | $1.76M 10-K · filed 2026-03-10 |
| 2024-09-30 | $217.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $777.00K derived: sum of 2 quarters · filed 2025-11-04 | $1.33M 10-Q · filed 2025-11-04 | $2.09M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $560.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $1.11M 10-Q · filed 2025-07-29 | $1.88M derived: sum of 3 quarters · filed 2025-07-29 | $2.77M derived: sum of 4 quarters · filed 2025-07-29 |
| 2024-03-31 | $553.00K 10-Q · filed 2025-05-05 | $1.32M derived: sum of 2 quarters · filed 2025-05-05 | $2.21M derived: sum of 3 quarters · filed 2025-05-05 | $3.18M derived: sum of 4 quarters · filed 2025-05-05 |
| 2023-12-31 | $763.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $1.65M derived: sum of 2 quarters · filed 2025-03-11 | $2.63M derived: sum of 3 quarters · filed 2025-03-11 | $3.62M 10-K · filed 2025-03-11 |
| 2023-09-30 | $890.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.87M derived: sum of 2 quarters · filed 2024-11-12 | $2.85M 10-Q · filed 2024-11-12 | $3.44M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $978.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $1.96M 10-Q · filed 2024-08-05 | $2.55M derived: sum of 3 quarters · filed 2024-08-05 | $3.85M derived: sum of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | $986.00K 10-Q · filed 2024-05-13 | $1.57M derived: sum of 2 quarters · filed 2024-05-13 | $2.87M derived: sum of 3 quarters · filed 2024-05-13 | $4.31M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $582.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $1.89M derived: sum of 2 quarters · filed 2024-03-18 | $3.33M derived: sum of 3 quarters · filed 2024-03-18 | $4.70M 10-K · filed 2024-03-18 |
| 2022-09-30 | $1.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $2.75M derived: sum of 2 quarters · filed 2023-11-13 | $4.12M 10-Q · filed 2023-11-13 | $5.30M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $1.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $2.82M 10-Q · filed 2023-08-07 | $3.99M derived: sum of 3 quarters · filed 2023-08-07 | $5.35M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $1.38M 10-Q · filed 2023-05-15 | $2.55M derived: sum of 2 quarters · filed 2023-05-15 | $3.91M derived: sum of 3 quarters · filed 2023-05-15 | $5.19M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $2.53M derived: sum of 2 quarters · filed 2023-03-20 | $3.82M derived: sum of 3 quarters · filed 2023-03-20 | $4.73M 10-K · filed 2023-03-20 |
| 2021-09-30 | $1.35M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-11-21 | $2.64M derived: sum of 2 quarters · filed 2022-11-21 | $3.55M 10-Q · filed 2022-11-21 | $4.37M derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-06-30 | $1.28M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2022-11-21 | $2.20M 10-Q/A · filed 2022-11-21 | $3.01M derived: sum of 3 quarters · filed 2022-11-21 | $3.81M derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-03-31 | $912.00K 10-Q · filed 2022-05-11 | $1.73M derived: sum of 2 quarters · filed 2022-05-11 | $2.53M derived: sum of 3 quarters · filed 2022-05-11 | $3.17M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $817.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $1.62M derived: sum of 2 quarters · filed 2022-03-22 | $2.26M derived: sum of 3 quarters · filed 2022-03-22 | $2.69M 10-K · filed 2022-03-22 |
| 2020-09-30 | $799.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.45M derived: sum of 2 quarters · filed 2021-11-10 | $1.88M 10-Q · filed 2021-11-10 | $2.36M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $647.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $1.08M 10-Q · filed 2021-08-09 | $1.56M derived: sum of 3 quarters · filed 2021-08-09 | $1.63M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | $431.00K 10-Q · filed 2021-05-11 | $918.00K derived: sum of 2 quarters · filed 2021-05-11 | $980.00K derived: sum of 3 quarters · filed 2021-05-11 | $991.00K derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $487.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $549.00K derived: sum of 2 quarters · filed 2021-03-16 | $560.00K derived: sum of 3 quarters · filed 2021-03-16 | $572.00K 10-K · filed 2021-03-16 |
| 2019-09-30 | $62.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $73.00K derived: sum of 2 quarters · filed 2020-11-10 | $85.00K 10-Q · filed 2020-11-10 | $99.00K derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | $23.00K 10-Q · filed 2020-07-28 | $37.00K derived: sum of 3 quarters · filed 2020-07-28 | |
| 2019-03-31 | $12.00K 10-Q · filed 2020-05-11 | $26.00K derived: sum of 2 quarters · filed 2020-05-11 | ||
| 2018-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $114.00K 10-K · filed 2020-03-25 | ||
| 2018-09-30 | $100.00K 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |